Market Overview:
The global quetiapine market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising prevalence of mental disorders, increasing awareness about mental health, and growing demand for quetiapine in emerging markets. However, patent expiry of key products and stringent regulatory environment are some of the major factors that are likely to restrain the growth of this market during the forecast period. On the basis of type, the global quetiapine market is segmented into purity 97%, purity 98%, and other. The purity 97% segment is expected to account for a major share of the global quetiapine market during the forecast period owing to its high demand among patients suffering from various mental disorders. On the basis of application, adult accounts for a majority share in terms of revenue generated by this market due to high prevalence rateof mental disorders among adults across different geographies.
 Industry Outlook.svg)
Product Definition:
Quetiapine (CAS 111974-69-7) is a drug used to treat schizophrenia, bipolar disorder, and depression. It belongs to a class of drugs called atypical antipsychotics.
Purity 97%:
Purity 97% is a colorless and odorless liquid that has been used as an intermediate in the production of various chemicals. It is also used as a solvent for producing quetiapine, which has been approved by the U.S. FDA and European Medicines Agency (EMA) for clinical use.
Purity 98%:
Purity 98% is a colorless and highly viscous liquid with an odor similar to that of turpentine. It has a density of 0.98 g/mL and isopropyl alcohol content of 99%. Purity 98% can be used as an alternative to benzene, chloroform, ethylene glycol, acetone, methylene chloride or any other organic solvent for the extraction process.
Application Insights:
The major applications of quetiapine include the treatment of schizophrenia and bipolar disorder. The adult application segment dominated the global market in 2017, accounting for over 60% share in terms of revenue. Schizophrenia is a chronic mental illness that affects about 1.2 billion people globally, according to the World Health Organization (WHO). Treatment with antipsychotics is highly effective in reducing symptoms of schizophrenia such as hallucinations and delusions. However, adverse effects associated with these drugs are also significant concerns for patients and their families when choosing between different treatments options available for schizophrenic disorders.
The aged application segment is expected to grow at a lucrative rate during the forecast period owing to increasing geriatric population across various regions including North America, Europe, Asia Pacific.
Regional Analysis:
Asia Pacific was the largest regional market in 2017 and is expected to maintain its position during the forecast period. The presence of major manufacturers in China, along with increased demand from countries such as India, Japan, and South Korea is anticipated to drive growth. In addition, growing awareness about atypical antipsychotic drugs among patients and physicians will support market development.
The European region accounted for a significant share of revenue in 2017 owing to high prevalence of schizophrenia among the population coupled with favorable government initiatives for improving mental health care access. Moreover, increasing funding by organizations such as EU’s Horizon 2020 research & innovation program supports new drug development which will further boost growth over the forecast period. North America region is expected witness steady growth due to factors such as rising geriatric population prone to neuropsychiatric disorders coupled with growing awareness about atypical antipsychotics usage rates amongst patients suffering from schizophrenia spectrum disorders including bipolar disorder and depression etc.
Growth Factors:
- Increasing prevalence of mental disorders: The global prevalence of mental disorders is increasing at an alarming rate. According to the World Health Organization (WHO), around 450 million people suffer from some form of mental disorder, which is nearly one-sixth of the world's population. This number is expected to increase to 615 million by 2030. Quetiapine is a highly effective treatment for various mental disorders such as schizophrenia, bipolar disorder, and major depressive disorder. Hence, the demand for quetiapine is expected to rise in the coming years.
- Growing awareness about psychiatric medications: There has been a growing awareness about psychiatric medications in recent years due to increasing incidences of mental health problems across the globe. This has led to an increase in demand for quetiapine and other psychiatric drugs worldwide.
Scope Of The Report
Report Attributes
Report Details
Report Title
Quetiapine (CAS 111974-69-7) Market Research Report
By Type
Purity 97%, Purity 98%, Other
By Application
Adult, Aged
By Companies
BOC Sciences, EMMX Biotechnology, Toronto Research Chemicals, Waterstone Technology, AlliChem, Nanjing Chemlin Chemical, XiaoGan ShenYuan ChemPharm, Wuhan Fortuna Chemical, Shanghai Haoyuan Chemexpress, Nanjing Sunlida Biological Technology
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
243
Number of Tables & Figures
171
Customization Available
Yes, the report can be customized as per your need.
Global Quetiapine (CAS 111974-69-7) Market Report Segments:
The global Quetiapine (CAS 111974-69-7) market is segmented on the basis of:
Types
Purity 97%, Purity 98%, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Adult, Aged
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- BOC Sciences
- EMMX Biotechnology
- Toronto Research Chemicals
- Waterstone Technology
- AlliChem
- Nanjing Chemlin Chemical
- XiaoGan ShenYuan ChemPharm
- Wuhan Fortuna Chemical
- Shanghai Haoyuan Chemexpress
- Nanjing Sunlida Biological Technology
 Market Overview.svg)
Highlights of The Quetiapine (CAS 111974-69-7) Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Purity 97%
- Purity 98%
- Other
- By Application:
- Adult
- Aged
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Quetiapine (CAS 111974-69-7) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Quetiapine is an antipsychotic medication. It works by blocking chemicals in the brain that may cause symptoms such as delusions, hallucinations, and mood swings.
Some of the major companies in the quetiapine (cas 111974-69-7) market are BOC Sciences, EMMX Biotechnology, Toronto Research Chemicals, Waterstone Technology, AlliChem, Nanjing Chemlin Chemical, XiaoGan ShenYuan ChemPharm, Wuhan Fortuna Chemical, Shanghai Haoyuan Chemexpress, Nanjing Sunlida Biological Technology.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Quetiapine (CAS 111974-69-7) Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Quetiapine (CAS 111974-69-7) Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Quetiapine (CAS 111974-69-7) Market - Supply Chain
4.5. Global Quetiapine (CAS 111974-69-7) Market Forecast
4.5.1. Quetiapine (CAS 111974-69-7) Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Quetiapine (CAS 111974-69-7) Market Size (000 Units) and Y-o-Y Growth
4.5.3. Quetiapine (CAS 111974-69-7) Market Absolute $ Opportunity
5. Global Quetiapine (CAS 111974-69-7) Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Quetiapine (CAS 111974-69-7) Market Size and Volume Forecast by Type
5.3.1. Purity 97%
5.3.2. Purity 98%
5.3.3. Other
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Quetiapine (CAS 111974-69-7) Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Quetiapine (CAS 111974-69-7) Market Size and Volume Forecast by Application
6.3.1. Adult
6.3.2. Aged
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Quetiapine (CAS 111974-69-7) Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Quetiapine (CAS 111974-69-7) Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Quetiapine (CAS 111974-69-7) Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Quetiapine (CAS 111974-69-7) Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Quetiapine (CAS 111974-69-7) Demand Share Forecast, 2019-2029
9. North America Quetiapine (CAS 111974-69-7) Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Quetiapine (CAS 111974-69-7) Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Quetiapine (CAS 111974-69-7) Market Size and Volume Forecast by Application
9.4.1. Adult
9.4.2. Aged
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Quetiapine (CAS 111974-69-7) Market Size and Volume Forecast by Type
9.7.1. Purity 97%
9.7.2. Purity 98%
9.7.3. Other
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Quetiapine (CAS 111974-69-7) Demand Share Forecast, 2019-2029
10. Latin America Quetiapine (CAS 111974-69-7) Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Quetiapine (CAS 111974-69-7) Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Quetiapine (CAS 111974-69-7) Market Size and Volume Forecast by Application
10.4.1. Adult
10.4.2. Aged
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Quetiapine (CAS 111974-69-7) Market Size and Volume Forecast by Type
10.7.1. Purity 97%
10.7.2. Purity 98%
10.7.3. Other
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Quetiapine (CAS 111974-69-7) Demand Share Forecast, 2019-2029
11. Europe Quetiapine (CAS 111974-69-7) Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Quetiapine (CAS 111974-69-7) Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Quetiapine (CAS 111974-69-7) Market Size and Volume Forecast by Application
11.4.1. Adult
11.4.2. Aged
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Quetiapine (CAS 111974-69-7) Market Size and Volume Forecast by Type
11.7.1. Purity 97%
11.7.2. Purity 98%
11.7.3. Other
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Quetiapine (CAS 111974-69-7) Demand Share, 2019-2029
12. Asia Pacific Quetiapine (CAS 111974-69-7) Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Quetiapine (CAS 111974-69-7) Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Quetiapine (CAS 111974-69-7) Market Size and Volume Forecast by Application
12.4.1. Adult
12.4.2. Aged
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Quetiapine (CAS 111974-69-7) Market Size and Volume Forecast by Type
12.7.1. Purity 97%
12.7.2. Purity 98%
12.7.3. Other
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Quetiapine (CAS 111974-69-7) Demand Share, 2019-2029
13. Middle East & Africa Quetiapine (CAS 111974-69-7) Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Quetiapine (CAS 111974-69-7) Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Quetiapine (CAS 111974-69-7) Market Size and Volume Forecast by Application
13.4.1. Adult
13.4.2. Aged
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Quetiapine (CAS 111974-69-7) Market Size and Volume Forecast by Type
13.7.1. Purity 97%
13.7.2. Purity 98%
13.7.3. Other
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Quetiapine (CAS 111974-69-7) Demand Share, 2019-2029
14. Competition Landscape
14.1. Global Quetiapine (CAS 111974-69-7) Market: Market Share Analysis
14.2. Quetiapine (CAS 111974-69-7) Distributors and Customers
14.3. Quetiapine (CAS 111974-69-7) Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. BOC Sciences
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. EMMX Biotechnology
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Toronto Research Chemicals
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Waterstone Technology
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. AlliChem
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Nanjing Chemlin Chemical
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. XiaoGan ShenYuan ChemPharm
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Wuhan Fortuna Chemical
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Shanghai Haoyuan Chemexpress
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Nanjing Sunlida Biological Technology
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
